Jonathan Violin - Chief Executive Officer, Viridian Therapeutics, Inc\de

As of May 4, 2022


Jonathan Violin Net Worth

  • Net worth is estimated to be at least $3.71M
  • Owns at least 510,905 units of Viridian Therapeutics, Inc\de stock
  • Sold an estimated value of $2.06M in the last year at Viridian Therapeutics, Inc\de

Jonathan Violin Trading

  • Largest sale of shares was 30,000 units , worth over $572.82K on February 3, 2022
  • In total has made about 6 transactions over a year
  • Usually trades in December, April, January, May, March and February, with the busiest year in 2022
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Jonathan Violin Mailing Address

  • Mailing address is 955 Chesterbrook Boulevard Suite 200 Chesterbrook PA 19087 PA

Viridian Therapeutics, Inc\de Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
William S. Marshall, Ph.D. 2020 $424,832 $ $585,128 $1,176,859 $2,186,819
William S. Marshall, Ph.D. 2019 $521,000 $ $551,302 $3,640 $1,075,942
Lee Rauch 2020 $256,436 $270,500 $1,139,677 $3,798 $1,670,411
Jason A. Leverone 2020 $365,650 $ $112,715 $4,655 $483,020
Jason A. Leverone 2019 $355,000 $ $178,223 $4,584 $537,807
Diana Escolar, M.D. 2020 $417,473 $277,780 $164,492 $5,873 $865,618
Diana Escolar, M.D. 2019 $372,600 $111,780 $59,408 $6,217 $550,005
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1590750/000159075021000054/vrdn-20210430defx14a.htm

Viridian Therapeutics, Inc\de Insider Trading

  • The most recent transaction was 30,000 units sold on May 4, 2022 by Jonathan Violin worth over $391.2K
  • In the last year, insiders at Viridian Therapeutics, Inc\de sold an estimated value of $2.06M and bought an estimated value of $12.2M
  • The most active traders are Jonathan Violin, Chief Executive Officer,  Kristian Humer, CFO and CBO,  and Arlene Morris, Director
  • Insider trading is most common in February, with the busiest year in 2021

Viridian Therapeutics, Inc.\DE Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1